Worg Pharma announced the completion of over 1.1 billion RMB in Series C financing.

The biopharmaceutical company Worg Pharma completes nearly 400 million RMB Series B financing

Worg Pharmaceuticals (Worg), a clinical stage biopharmaceutical company developing new treatments for allergic and autoi...

Worg won the "second prize" in Zhejiang Province in 2021 "maker China" and "Zhejiang good project" innovation and entrep...

Expands immunotherapy pipeline with potential first in class treatments for a range of autoimmune diseases

Today at the Entrepreneurship Competition Hangzhou 2021, Worg pharmaceuticals received the sole first prize of "Innovato...

Innovative pharmaceutical company Worg Pharma (“Worg”) and Global company with leading open-access biologics technology ...